BIOWEAR Trademark

Trademark Overview


On Saturday, November 16, 2024, a trademark application was filed for BIOWEAR with the United States Patent and Trademark Office. The USPTO has given the BIOWEAR trademark a serial number of 98857154. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, May 15, 2025. This trademark is owned by LEXINGTON BIOMEDICAL INC.. The BIOWEAR trademark is filed in the Medical Instrument Products category with the following description:

Non-invasive medical devices for use in treating cardiovascular disease
biowear

General Information


Serial Number98857154
Word MarkBIOWEAR
Filing DateSaturday, November 16, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, May 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkBIO WEAR
Goods and ServicesNon-invasive medical devices for use in treating cardiovascular disease

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, November 16, 2024
Primary Code010
First Use Anywhere DateThursday, January 15, 2015
First Use In Commerce DateMonday, August 10, 2015

Trademark Owner History


Party NameLEXINGTON BIOMEDICAL INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Saturday, November 16, 2024NEW APPLICATION ENTERED
Saturday, April 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 12, 2025ASSIGNED TO EXAMINER
Saturday, November 16, 2024APPLICATION FILING RECEIPT MAILED
Thursday, May 15, 2025NON-FINAL ACTION WRITTEN
Thursday, May 15, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 15, 2025NON-FINAL ACTION E-MAILED